Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Gastroenterology|December 30, 2022
A combination of liver stiffness and international normalized ratio is an ideal prognostic predictor of portosystemic shunt occlusion in patients with portal hypertensionTsuyoshi Ishikawa, Maho Egusa, Tsuyoshi Fujioka, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 2, 2021
Albumin-bilirubin score as a useful predictor of energy malnutrition in patients with hepatocellular carcinomaYurika Kotoh, Issei Saeki, Takahiro Yamasaki, et al.
Pigment Cell Research|September 13, 2006
Oculocutaneous albinism type 4: six novel mutations in the membrane-associated transporter protein gene and their phenotypesKatsuhiko Inagaki, Tamio Suzuki, Shiro Ito, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 3, 2013
Association of tyrosine with insulin resistance in hepatitis C virus-related chronic liver diseaseTakashi Oono, Takahiro Yamasaki, Junichi Zaitsu, et al.
Hepatology International|May 15, 2023
Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinomaIssei Saeki, Yutaka Suehiro, Yurika Yamauchi, et al.
Cancers|March 29, 2020
Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib TreatmentIssei Saeki, Takahiro Yamasaki, Satoyoshi Yamashita, et al.
Cancers|June 10, 2023
Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular CarcinomaNorikazu Tanabe, Issei Saeki, Yuki Aibe, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 24, 2023
Double cancer of primary hepatic angiosarcoma and hepatocellular carcinoma treated with atezolizumab plus bevacizumabYurika Yamauchi, Issei Saeki, Takahiro Yamasaki, et al.
Tissue Engineering. Part B, Reviews|January 24, 2014
Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cellsShuji Terai, Taro Takami, Naoki Yamamoto, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 4, 2025
Employment Status of Patients With Liver Disease: A Nationwide Questionnaire Survey in JapanYoshio Tokumoto, Yoichi Hiasa, Yoshihito Uchida, et al.
Pageof 3